ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Social Stream



ProQR Therapeutics N.V. - Ordinary Shares (PRQR): $7.19

-0.17 (-2.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRQR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

ProQR Therapeutics NV (PRQR) Price Targets From Analysts

Use the tables below to see what analysts covering ProQR Therapeutics NV think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $33 $18 $22.75 $7.6 199.34%

The Trend in the Analyst Price Target


Over the past 18 months, PRQR's average price target has gone down $0.92.

Over the past 18 months, PRQR's average upside potential has been 308.32%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-07 4 33.00000 18.00000 22.75000 8.41 170.51%
2021-07-02 7 39.57211 17.80745 25.34514 6.51 289.33%
2021-07-02 7 39.60979 17.82441 25.36927 6.51 289.7%
2021-07-02 7 39.37001 17.71650 25.21569 6.51 287.34%
2021-07-02 7 39.25528 17.66488 25.14222 6.51 286.21%
2021-07-02 7 39.58011 17.81105 25.35026 6.51 289.4%
2021-07-02 7 39.46739 17.76033 25.27806 6.51 288.3%
2021-07-02 7 39.22160 17.64972 25.12064 6.51 285.88%
2021-07-02 7 39.33632 17.70135 25.19412 6.51 287.01%
2021-04-15 6 45.15092 18.47088 26.67529 6.18 331.64%
2021-04-15 7 45.15092 18.47088 26.67529 6.18 331.64%
2021-04-15 6 45.02007 18.41735 26.59799 6.18 330.39%
2021-04-15 7 45.02007 18.41735 26.59799 6.18 330.39%
2021-04-15 6 44.41549 18.17002 26.24080 6.18 324.61%
2021-04-15 7 44.41549 18.17002 26.24080 6.18 324.61%
2021-04-15 6 44.84288 18.34486 26.49331 6.18 328.69%
2021-04-15 7 44.84288 18.34486 26.49331 6.18 328.69%
2021-04-15 6 45.08605 18.44434 26.63697 6.18 331.02%
2021-04-15 7 45.08605 18.44434 26.63697 6.18 331.02%
2020-05-13 NA 36.27000 18.40000 23.67000 NA NA%

PRQR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


PRQR's average broker recommendation rating improved by 0.62 over the prior 31 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • PRQR has a higher upside potential (average analyst target price relative to current price) than 92.37% of all US stocks.
  • ProQR Therapeutics NV's variance in analysts' estimates is less than 14.87% of all US stocks.
  • ProQR Therapeutics NV's number of analysts covering the stock is higher than 32.23% of Pharmaceutical Products stocks.
  • ProQR Therapeutics NV's average analyst price target is greater than 34.37% of all US stocks.

In the Pharmaceutical Products industry, ABCL, OTIC and RLMD are the three stocks most similar to ProQR Therapeutics NV regarding the price target and analyst recommendation information presented here.

What is the outlook for PRQR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6318 seconds.